Mouse HMGB-1(Highmobility group protein B1) ELISA Kit
中文名称:小鼠高迁移率族蛋白B1(HMGB-1)酶联免疫吸附测定试剂盒

Price:
- 反应性: Mouse
- 检测范围: 15.63-1000 pg/mL
- 灵敏度: 9.38 pg/mL
产品应用 | ELISA |
检测原理 | 本试剂盒采用双抗体夹心ELISA法。用抗小鼠HMGB-1抗体包被于酶标板上,实验时样品(或标准品)中的小鼠HMGB-1会与包被抗体结合。后依次加入生物素化的抗小鼠HMGB-1抗体和辣根过氧化物酶标记的亲和素,抗小鼠HMGB-1抗体与结合在包被抗体上的小鼠HMGB-1结合,生物素与亲和素特异性结合而形成免疫复合物,游离的成分被洗去。加入显色底物(TMB),TMB在辣根过氧化物酶的催化下呈现蓝色,加终止液后变成黄色。用酶标仪在450 nm波长处测OD值,HMGB-1浓度与OD450值之间呈正比,通过绘制标准曲线计算出样品中HMGB-1的浓度。 |
反应类型 | Sandwich-ELISA |
规格 |
96 T
/ 48 T
/ 96 T × 5
|
反应时间 | 3 h 30 min |
反应性 | Mouse |
检测方法 | 比色法;ELISA;夹心法 |
检测范围 | 15.63-1000 pg/mL |
灵敏度 | 9.38 pg/mL |
样本体积 | 100 μL |
样本类型 | 血清、血浆或其他生物体液 |
特异性 | 可检测样本中的小鼠HMGB-1,且与其它类似物无明显交叉反应 |
精密度 | 板内,板间变异系数均<10% |
回收率 | 80%-120% |
储存条件 | 2-8℃ |
有效期 | 12个月 |
操作步骤 | ![]() |
数据处理 |
-
HMGB1 inhibition blocks ferroptosis and oxidative stress to ameliorate sepsis-induced acute lung injury by activating the Nrf2 pathway
IF: 2.7Journal: KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2024)Reactivity:MouseSample Type:serum -
Neuroprotective effect of Naringin by modulation of Klotho and HMGB1- TLR4 axis in PTZ-induced kindling in mice
IF: 2.5Journal: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2024)Reactivity:MouseSample Type:hippocampus tissue,cortex tissue -
Laser-Activatable in Situ Vaccine Enhances Cancer-Immunity Cycle
IF: 29.4 -
Relieving thrombo-inflammation with acid-triggered polymersomes toward ischemic stroke therapy
IF: 17.4 -
In Situ Attached Photothermal Immunomodulation-Enhanced Nanozyme for the Inhibition of Postoperative Malignant Glioma Recurrence
IF: 17.1 -
A photo-triggered self-accelerated nanoplatform for multifunctional image-guided combination cancer immunotherapy
IF: 16.6 -
Nano-Econazole Enhanced PD-L1 Checkpoint Blockade for Synergistic Antitumor Immunotherapy against Pancreatic Ductal Adenocarcinoma
IF: 13.300 -
Dying tumor cells-inspired vaccine for boosting humoral and cellular immunity against cancer
IF: 10.8 -
Mitochondrial-targeted brequinar liposome boosted mitochondrial-related ferroptosis for promoting checkpoint blockade immunotherapy in bladder cancer
IF: 10.8 -
RNA-based modulation of macrophage-mediated efferocytosis potentiates antitumor immunity in colorectal cancer
IF: 10.8

暂无文件,请在搜索框输入识别码查询相关文件

名称 | 状态 | 有效期至 | 操作 | |
---|---|---|---|---|
{{item.文件名}} | {{item.status_str}} | {{item.timestamp_str}} | 点击查看 点击预览 |
*注:请在有效期内下载相关文件,过期后页面内将不提供文件下载及预览!